Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients

Auris Nasus Larynx

Volumn 37, Issue 1, 2010, Pages 29-32

  Alpay, Hayrettin Cengiz ^a   Etem, Ebru Onalan ^a   Kaygusuz, Irfan ^a   Yüce, Hüseyin ^a   Karlidag, Turgut ^a   Keles, Erol ^a   Orhan, Israfil ^a   Yalcin, Sinasi ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

TLR4 gene polymorphism; Tympanosclerosis

Indexed keywords

ASPARTIC ACID; DNA; GLYCINE; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC OTITIS MEDIA; CONTROLLED STUDY; DNA ISOLATION; EARDRUM DISEASE; EARDRUM PERFORATION; FEMALE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR SURGERY; MUTATION RATE; MUTATIONAL ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TYMPANOSCLEROSIS;

ADOLESCENT; ADULT; ALLELES; CHRONIC DISEASE; DNA; DNA PRIMERS; FEMALE; HUMANS; MALE; OTITIS MEDIA; OTOSCLEROSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TOLL-LIKE RECEPTOR 4; TYMPANIC MEMBRANE; TYMPANIC MEMBRANE PERFORATION; YOUNG ADULT;

EID: 71849118426     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2009.03.001     Document Type: Article

References (31)

1. Akyi{dotless}ldi{dotless}z A.N. Kronik (süpüratif) otitis media. In: Akyi{dotless}ldi{dotless}z A.N. (Ed). Kulak hastali{dotless}klari{dotless} ve mikrocerrahisi vol. 1 (1998), Bilimsel Ti{dotless}p Yayi{dotless}nevi, Ankara 337-472
2. Plester D. Tympanosclerosis. J Otolaryngol Soc Aust 3 (1972) 325-326
3. Olsson M., Dalsgaard C.J., Haegerstrand A., Rosenqvist M., Rydén L., and Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 23 (1994) 1162-1170
4. Austin D.F. Reconstructive techniques for tympanosclerosis. Ann Otol Rhinol Laryngol 97 (1988) 670-674
5. Sheehy J.L., and Huose W.F. Tympanosclerosis. Arch Otolaryngol 76 (1962) 151-157
6. Tos M., Lau T., Arndal H., and Plate S. Tympanosclerosis of the middle ear: late results and surgical treatment. J Laryngol Otol 104 (1990) 685-689
7. Smyth G.D.L. Tympanosclerosis. Laryngol Otol 86 (1972) 9-14
8. Schuknecht H.F., Mc Gee T.M., and Oleksiuk S. Comments on tympanoplasty. Laryngocope 70 (1961) 1157-1168
9. Emonts M., Veenhoven R.H., Wiertsema S.P., Houwing-Duistermaat J.J., Walraven V., de Groot R., et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media pediatrics 120 (2007) 814-823
10. Sanchez E., Orozco G., and Martin J. Toll-like receptor and human pathology. Immunologia 23 (2004) 328-338
11. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
12. Koc A., and Uneri C. Genetic predisposition for tympanosclerotic degeneration. Eur Arch Otorhinolaryngol 259 (2002) 180-183
13. Koc A., and Uneri C. Sex distribution in children with tympanosclerosis after insertion of a tympanostomy tube. Eur Arch Otorhinolaryngol 258 (2001) 16-19
14. Pirodda A., Ferri G.G., Bruzzi C., Marini M., and Faggioli G. Possible relationship between tympanosclerosis and atherosclerosis. Acta Otolaryngol 124 June (2004) 574-576
15. Lorenz E., Hallman M., Martilla R., Haataja R., and Schwartz D.A. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 52 (2002) 373-376
16. Mattsson C., Carlsson L., Marklund S.L., and Hellström S. Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa. Laryngoscope 107 (1997) 200-205
17. Spratley J.E., Hellström S.O., Mattsson C.K., and Clemente M.P. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes a study in the rat. Ann Otol Rhinol Laryngol 110 (2001) 585-591
18. Mattsson C., Marklund S.L., and Hellström S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106 (1997) 513-518
19. Mattsson C., and Hellström S. Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254 (1997) 425-429
20. Gorur K., Ozcan C., Polat A., Unal M., Tamer L., and Cinel I. The antioxidant and antiapoptotic activities of selenium in the prevention of myringosclerosis in rats. J Laryngol Otol 116 (2002) 426-429
21. Ozcan C., Polat G., Gorur K., Talas D.U., Bagdatoglu O., and Cinel I. The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: an experimental study in myringosclerosis. Pharmacol Res 45 (2002) 5-9
22. Ozcan C., Gorur K., Cinel L., Talas D.U., Unal M., and Cinel I. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 63 (2002) 179-184
23. Akbas Y., Pata Y.S., Gorur K., Polat G., Polat A., Ozcan C., et al. The effect of l-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 184 (2003) 107-112
24. Karlidag T., Ilhan N., Kaygusuz I., Keles E., and Yalcin S. Comparison of free radicals and antioxidant enzymes in chronic otitis media with and without tympanosclerosis. Laryngoscope 114 (2004) 85-89
25. Polat S., Ozturk O., Uneri C., Yuksel M., Haklar G., Bozkurt S., et al. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin E treatment. Laryngoscope 114 (2004) 720-725
26. Bluestone C.D., Stephenson J.S., and Martin L.M. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 11 (1992) 7-11
27. Yuan F.F., Marks K., Wong M., Watson S., de Leon E., McIntyre P.B., et al. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 86 March (2008) 268-270 [Epub January 8, 2008]
28. Mattsson C., Johansson, and Hellstrom S. Myringosclerosis develops within 9 h of myringotomized rats. ORL J Otorhinolaryngol Relat Spec 61 (1999) 31-36
29. 2 release by mitochondria and microsomes. Arch Biochem Biophys 217 (1982) 411-421
30. Mattsson C., Magnuson K., and Hellström S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 104 (1995) 625-632
31. Forséni M., Bagger-Sjöbäck D., and Hultcrantz M. A study of inflammatory mediators in the human tympanosclerotic middle ear. Arch Otolaryngol Head Neck Surg 127 (2001) 559-564